BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11861032)

  • 1. Overview of gender aspects of cardiac syndrome X.
    Kaski JC
    Cardiovasc Res; 2002 Feb; 53(3):620-6. PubMed ID: 11861032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac syndrome X in women: the role of oestrogen deficiency.
    Kaski JC
    Heart; 2006 May; 92 Suppl 3(Suppl 3):iii5-9. PubMed ID: 16614266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac syndrome X. Diagnosis, pathogenesis and management.
    Kaski JC; Aldama G; Cosín-Sales J
    Am J Cardiovasc Drugs; 2004; 4(3):179-94. PubMed ID: 15134470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microvascular angina and syndrome X].
    Kaski JC; Pérez Fernández R
    Rev Esp Cardiol; 2002; 55 Suppl 1():10-6. PubMed ID: 15626351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular angina in patients with syndrome X.
    Kaski JC; Russo G
    Z Kardiol; 2000; 89 Suppl 9():IX/121-5. PubMed ID: 11151781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism.
    Rosano GM; Kaski JC; Arie S; Pereira WI; Horta P; Collins P; Pileggi F; Poole-Wilson PA
    Eur Heart J; 1996 Aug; 17(8):1175-80. PubMed ID: 8869858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms.
    Adamson DL; Webb CM; Collins P
    Menopause; 2001; 8(4):233-8. PubMed ID: 11449079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammation and endothelial dysfunction in the pathogenesis of cardiac syndrome X.
    Gil-Ortega I; Marzoa Rivas R; Ríos Vázquez R; Kaski JC
    Future Cardiol; 2006 Jan; 2(1):63-73. PubMed ID: 19804133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X).
    Ong P; Athanasiadis A; Mahrholdt H; Borgulya G; Sechtem U; Kaski JC
    Clin Res Cardiol; 2012 Aug; 101(8):673-81. PubMed ID: 22407462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
    Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
    Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndrome X in women is associated with oestrogen deficiency.
    Rosano GM; Collins P; Kaski JC; Lindsay DC; Sarrel PM; Poole-Wilson PA
    Eur Heart J; 1995 May; 16(5):610-4. PubMed ID: 7588891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X.
    Rosano GM; Peters NS; Lefroy D; Lindsay DC; Sarrel PM; Collins P; Poole-Wilson PA
    J Am Coll Cardiol; 1996 Nov; 28(6):1500-5. PubMed ID: 8917264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology.
    Lim TK; Choy AJ; Khan F; Belch JJ; Struthers AD; Lang CC
    Cardiovasc Ther; 2009; 27(1):49-58. PubMed ID: 19207480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms.
    Roqué M; Heras M; Roig E; Masotti M; Rigol M; Betriu A; Balasch J; Sanz G
    J Am Coll Cardiol; 1998 Jan; 31(1):139-43. PubMed ID: 9426032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angina pectoris caused by coronary microvascular spasm.
    Mohri M; Koyanagi M; Egashira K; Tagawa H; Ichiki T; Shimokawa H; Takeshita A
    Lancet; 1998 Apr; 351(9110):1165-9. PubMed ID: 9643687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study.
    Kaski JC; Rosano GM; Collins P; Nihoyannopoulos P; Maseri A; Poole-Wilson PA
    J Am Coll Cardiol; 1995 Mar; 25(4):807-14. PubMed ID: 7884081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of Ischemic Heart Disease.
    Kaski JC; Crea F; Gersh BJ; Camici PG
    Circulation; 2018 Oct; 138(14):1463-1480. PubMed ID: 30354347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease.
    Recio-Mayoral A; Rimoldi OE; Camici PG; Kaski JC
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):660-7. PubMed ID: 23643286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular dysfunction secondary to ischemia in women with angina and normal coronary angiograms.
    Peix A; González A; García EJ; Valiente J; Cabrera LO; Sixto S; Filgueiras CE; Cabalé B; Hechavarría S; González I; Carrillo R; García-Barreto D
    J Womens Health (Larchmt); 2009 Feb; 18(2):155-61. PubMed ID: 19183086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular dysfunction in the clinical setting: from mystery to reality.
    Herrmann J; Kaski JC; Lerman A
    Eur Heart J; 2012 Nov; 33(22):2771-2782b. PubMed ID: 22915165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.